Targeting EGFR Exon 20 Insertion-mutated Cancers – New Perspectives in Head and Neck Cancers – Lessons to Learn from Non-small Cell Carcinoma (NSCLC)

Targeting EGFR Exon 20 Insertion-mutated Cancers – New Perspectives in Head and Neck Cancers – Lessons to Learn from Non-small Cell Carcinoma (NSCLC)

Mutations in the tyrosine kinase (TKD) domain of the epidermal growth factor receptor (EGFR) are involved in the unfavorable therapeutic response through resistance to targeted molecular therapy. Data from the clinical experience of non-small cell lung carcinoma (NSCLC) treatment demonstrate the ben...

Full description

Bibliographic Details
Main Authors: Camil Ciprian MIRESTEAN, Roxana Irina IANCU, Dragos Teodor IANCU
Format: Article
Language:English
Published: Media Med Publicis 2022-09-01
Series:Modern Medicine
Subjects:
head and neck cancers
tki
egfr
hnscc
lung cancer
nsclc
amivantamab
exon 20
Online Access:https://medicinamoderna.ro/wp-content/uploads/2022/09/Targeting-EGFR-Exon-20-Insertion-mutated-Cancers-%E2%80%93-New-Perspectives-in-Head-and-Neck-Cancers.pdf

Internet

https://medicinamoderna.ro/wp-content/uploads/2022/09/Targeting-EGFR-Exon-20-Insertion-mutated-Cancers-%E2%80%93-New-Perspectives-in-Head-and-Neck-Cancers.pdf

Similar Items